These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 10887555)

  • 1. [Immunogenicity of the Heberbiovac-HB vaccine in doses of 10.5 and 2.5 micrograms in 6-9-year-old students].
    Díaz González M; Navia Molina O; Urbino López-Chávez A; Rodríguez Lay L; Bravo González JR; Pedroso Flaquet P
    Rev Cubana Med Trop; 1999; 51(1):46-9. PubMed ID: 10887555
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The immunogenicity of the Heberbiovac-HB vaccine in children].
    Díaz González M; Chiang Macía A; Díaz Acosta D; Bravo González JR; Rodríguez Lay L; Pedroso Flaquet P; López-Chávez AU
    Rev Cubana Med Trop; 1996; 48(3):195-8. PubMed ID: 9805051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The immunogenicity of the Heberbiovac-HB vaccine in the elderly].
    Pedroso Flaquet P; Díaz González M; Rodríguez Lay L; Bravo González R
    Rev Cubana Med Trop; 1996; 48(3):200-3. PubMed ID: 9805052
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Immunogenicity of the Heberbiovac-HB vaccine in the physically and mentally handicapped].
    Pedroso Flaquet P; Díaz González M; Rodríguez Lay L; Bravo González JR
    Rev Cubana Med Trop; 1997; 49(1):59-63. PubMed ID: 9685963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A comparative study between different regimens for administering 2 doses of the Cuban anti-hepatitis B vaccine].
    González-Griego Mde J; Cinza Z; Ortega A; Gali MM; Santoyo ME; García G; Delahanty A
    Rev Cubana Med Trop; 1998; 50(3):218-20. PubMed ID: 10349448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The reactogenicity of Heberbiovac-HB vaccine at different doses].
    Díaz González M; Navia Molina O; Bravo González JR; Pedroso Flaquet P; Urbino López A
    Rev Cubana Med Trop; 1995; 47(1):65-70. PubMed ID: 9805071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Immune-efficacy of recombinant vaccinia HB vaccine on middle school students of Uigur nationality].
    Li D
    Zhonghua Yu Fang Yi Xue Za Zhi; 1993 Mar; 27(2):74-6. PubMed ID: 8354108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Immunogenicity and efficacy of a new recombinant DNA vaccine for hepatitis B virus in Peru].
    Lozano M A; Caycho O J; Antunez de Mayolo A; Vera D; Posadas R D
    Rev Gastroenterol Peru; 2003; 23(4):259-64. PubMed ID: 14716420
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A two-dose schedule for combined hepatitis A and B vaccination in children aged 6-15 years.
    Kurugöl Z; Mutlubaş F; Ozacar T
    Vaccine; 2005 Apr; 23(22):2876-80. PubMed ID: 15780736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Protective efficacy of Heberbiovac HB at different dosage in physically and mentally-handicapped children].
    Pedroso Flaquet P; Díaz González M; Rodríguez Lay L
    Rev Cubana Med Trop; 2010; 62(1):58-64. PubMed ID: 23431638
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunogenicity of two paediatric doses of monovalent hepatitis B or combined hepatitis A and B vaccine in 8-10-year-old children.
    Duval B; Gîlca V; Boulianne N; Deceuninck G; Rochette L; De Serres G
    Vaccine; 2005 Jul; 23(31):4082-7. PubMed ID: 15963363
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunogenicity and safety of yeast-derived recombinant hepatitis B vaccine (Heberbiovac HB) in South African children.
    Mphahlele MJ; Burnett RJ; Kyaw T; Schoeman HS; Aspinall S
    S Afr Med J; 2004 Apr; 94(4):280-1. PubMed ID: 15150941
    [No Abstract]   [Full Text] [Related]  

  • 13. [A five-year observation on efficacy of revaccination in children of non-response to hepatitis B vaccine].
    Zhuang GH; Yan H; Wang XL; Wu Q; Wang LR; Gao HY
    Zhonghua Yu Fang Yi Xue Za Zhi; 2006 Jan; 40(1):8-12. PubMed ID: 16620590
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low-dose intramuscular hepatitis B vaccination in medical students: 4-year follow-up.
    Erensoy S; Bilgiç A; Arda B; Ozer O
    Infection; 2002 Oct; 30(5):303-5. PubMed ID: 12382091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term immunogenicity and efficacy of a recombinant hepatitis B vaccine in Egyptian children.
    el-Sawy IH; Mohamed ON
    East Mediterr Health J; 1999 Sep; 5(5):922-32. PubMed ID: 10983531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunogenicity of low-dose and conventional-dose recombinant hepatitis B vaccines in healthy adolescents in India.
    Rana SS; Singhal R; Gupta RK; Sharma D; Kar P
    Singapore Med J; 2004 Sep; 45(9):427-9. PubMed ID: 15334286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Immunogenicity of vaccines against viral hepatitis A and B in the population above 40 years of age -- impact of risk factors].
    Chlíbek R; Smetana J; Sindelár R; Cecetková B; Prymula R; Kohl I
    Epidemiol Mikrobiol Imunol; 2007 Aug; 56(3):119-28. PubMed ID: 17900060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunogenicity and safety of an experimental adjuvanted hepatitis B candidate vaccine in liver transplant patients.
    Nevens F; Zuckerman JN; Burroughs AK; Jung MC; Bayas JM; Kallinowski B; Rivas EF; Duvoux C; Neuhaus P; Saliba F; Buti M; Zarski JP; Pons F; Vanlemmens C; Hamtiaux V; Stoffel M
    Liver Transpl; 2006 Oct; 12(10):1489-95. PubMed ID: 16964595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Specific T cell immune response in chronic hepatitis B patients treated with different doses of recombinant hepatitis B vaccine].
    Xu QH; Zhang XH; Xie DY; Li JG; Chong YT; Yang L; Lu WL; Gao ZL
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2007 Dec; 21(4):334-6. PubMed ID: 18322594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparison of two different vaccination schemes against Hepatitis A and B in Mexican children and adolescents].
    González-Huezo MS; Sánchez-Avila F; García Mayol M; Castro Narro G; Sixtos S; Lisker-Melman M; Kershenobich D
    Rev Gastroenterol Mex; 2003; 68(4):271-6. PubMed ID: 15125329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.